Edwards Larry G.

About Edwards Larry G.

Larry G. Edwards is a biopharmaceutical executive whose career has centered on commercializing innovative therapies for acute-care and high-unmet-need indications. In July 2020, he was appointed President and Chief Executive Officer of La Jolla Pharmaceutical Company, a company focused on therapies for life-threatening diseases. In that role, he led the organization as it advanced the commercialization of key approved products, including GIAPREZA and XERAVA. ([globenewswire.com](https://www.globenewswire.com/news-release/2020/07/28/2069036/0/en/Larry-Edwards-Appointed-President-and-Chief-Executive-Officer-of-La-Jolla-Pharmaceutical-Company.html)) Before joining La Jolla, Edwards held multiple leadership positions at Tetraphase Pharmaceuticals from 2015 to 2020, ultimately serving as Chief Executive Officer. Earlier, he worked at Cubist Pharmaceuticals from 2014 to 2015 as Senior Director of Marketing for the Gram-negative Franchise. From 1999 to 2014, he served in a series of roles at Merck & Co., most recently as Global Marketing Director for Clostridium Difficile and new infectious disease products. That background suggests deep expertise in commercial strategy, hospital-focused product launches, and franchise management in infectious disease and critical-care markets. ([globenewswire.com](https://www.globenewswire.com/news-release/2020/07/28/2069036/0/en/Larry-Edwards-Appointed-President-and-Chief-Executive-Officer-of-La-Jolla-Pharmaceutical-Company.html)) At La Jolla, his responsibilities included expanding patient access to core therapies and supporting the company’s commercial execution in intensive care and severe infection settings. Public filings show that he served as a director, President, and Chief Executive Officer through his resignation effective March 31, 2023. During his tenure, La Jolla also completed the integration of Tetraphase and continued building its commercialization footprint. ([sec.gov](https://www.sec.gov/Archives/edgar/data/920465/000156459022009182/ljpc-10k_20211231.htm)) Edwards holds a B.S. degree in business and healthcare administration from Ohio University. Overall, his career profile is that of a commercially oriented pharmaceutical leader with experience scaling approved therapies, navigating regulated markets, and managing organizations serving critically ill patients. ([globenewswire.com](https://www.globenewswire.com/news-release/2020/07/28/2069036/0/en/Larry-Edwards-Appointed-President-and-Chief-Executive-Officer-of-La-Jolla-Pharmaceutical-Company.html))